Skip to main content
. 2021 Sep 22;5:287. Originally published 2020 Dec 9. [Version 2] doi: 10.12688/wellcomeopenres.16320.2

Table 2. Primer details for Sanger sequencing the alpha-thalassaemia deletion region in HBA1 and HBA2.

Name Dir Genome Position Gene Genome Position Genome Position Primer Sequence (5'-3')
A2/3.7-F FWD 16:221882-221901 5' to HBA2 CCCCTCGCCAAGTCCACCC
HBA1_specific_F FWD 16:225771-225792 HBA1 CTCCAGCCGGTTCCAGCTATTG
HBA-5' SEQ REV REV 16:222930-222950 HBA2 16:226734-226754 HBA1 GGCCTTGACGTTGGTCTTGTC
HBA-3' SEQ FWD FWD 16:223310-223332 HBA2 16:227114-227136 HBA1 GGACCCGGTCAACTTCAAGGTGA
A2-R REV 16:223666-223684 3' to HBA2 AAAGCACTCTAGGGTCCAGCG
3.7-R REV 16:227698-227718 3' to HBA1 CCCCTCGCCAAGTCCACCC

α-thalassaemia PCR was undertaken using the standard protocol as described 19. PCR products were then sequenced using the primers above (see methods).

A2/3.7-F, A2-R and 3.7-R are primers used in the standard PCR assay for α -3.7-thalassaemia deletion.

HBA-5' SEQ REV and HBA-3' SEQ FWD were designed internal to the products to allow more coverage. All primer locations are identified in Figure 2